For those infected, it is important to know your best treatment options -- the right medicines and drugs that have been effective in reduci...

Zydus was the first abbreviated new drug application (ANDA) filer on Tofacitinib extended-release tablets 22 mg and thus holds 180-day excl...

The company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version o...

The drugs inhibit a family of enzymes inside hair follicles that are suspended in a resting state, restoring hair growth.

India's patent office has again rejected US drug major Pfizer's new patent application for its rheumatoid arthritis medicine, tofacitinib, ...

The base compound of the drug has been granted patents in India and Pfizer attempted to secure additional patents for the follow-up improve...

Standard treatments, such as steroid creams and oral medicines, commonly fail to relieve symptoms in patients with moderate to severe eczem...